Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin

Zhuocheng Yao, Luozhu Feng, Yining Zhao, Xiaodong Zhang, Lijiang Chen, Lingbo Wang, Ying Zhang, Yao Sun, Tieli Zhou, Jianming Cao

Microbiology Spectrum · 2022 · 32 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

Colistin is being considered “the last ditch” treatment in many infections caused by multidrug-resistant GNB clinical isolates, but colistin-resistant (Col-R) strains with different drug resistance mechanisms have appeared worldwide. Hence, it is of great significance to rejuvenate sensitization of clinical Col-R Gram-negative bacteria to colistin.

References

40